<html>
<head>PUBMED IDs for Apo2</head>
<body bgcolor='#C5F0F2'><h1>Apo2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/9242610/'>An antagonist decoy receptor and a death domain-containing receptor for TRAIL.</a> August 8  1997<br><a href='https://pubmed.ncbi.nlm.nih.gov/9382840/'>A novel receptor for Apo2L/TRAIL contains a truncated death domain.</a> February 21  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/9427646/'>Dominant-negative FADD inhibits TNFR60-, Fas/Apo1- and TRAIL-R/Apo2-mediated cell death but not gene induction.</a> March 21  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/10547074/'>Role of CD14 expression in the differentiation-apoptosis switch in human monocytic leukemia cells treated with 1alpha,25-dihydroxyvitamin D3 or dexamethasone in the presence of transforming growth factor beta1.</a> November 5  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10764042/'>Bag-1 and Bcl-2 gene transfer in malignant glioma: modulation of cell cycle regulation and apoptosis.</a> April 14  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/10811986/'>Expression of TRAIL (Apo2L), DR4 (TRAIL receptor 1), DR5 (TRAIL receptor 2) and TRID (TRAIL receptor 3) genes in multidrug resistant human acute myeloid leukemia cell lines that overexpress MDR 1 (HL60/Tax) or MRP (HL60/AR).</a> May 17  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/10823821/'>Inhibition of death receptor-mediated gene induction by a cycloheximide-sensitive factor occurs at the level of or upstream of Fas-associated death domain protein (FADD).</a> May 24  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/10980594/'>Secreted Frizzled-related proteins inhibit motility and promote growth of human malignant glioma cells.</a> September 12  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11059770/'>Apo2 ligand/TNF-related apoptosis-inducing ligand and death receptor 5 mediate the apoptotic signaling induced by ionizing radiation in leukemic cells.</a> November 4  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11095979/'>Genomic organization and transcriptional regulation of human Apo2/TRAIL gene.</a> November 30  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11146447/'>Chromosomal imbalances associated with response to chemotherapy and cytotoxic cytokines in human malignant glioma cell lines.</a> January 9  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11279540/'>Potential mechanisms of resistance to TRAIL/Apo2L-induced apoptosis in human promyelocytic leukemia HL-60 cells during granulocytic differentiation.</a> March 30  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11283615/'>Regulation of death receptor expression and TRAIL/Apo2L-induced apoptosis by NF-kappaB.</a> April 3  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11410525/'>Preferential induction of apoptosis by interferon (IFN)-beta compared with IFN-alpha2: correlation with TRAIL/Apo2L induction in melanoma cell lines.</a> June 19  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11495702/'>Additive effect of Apo2L/TRAIL and Adeno-p53 in the induction of apoptosis in myeloma cell lines.</a> August 10  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11550092/'>APRIL, a new member of the tumor necrosis factor family, modulates death ligand-induced apoptosis.</a> September 11  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11561060/'>Preclinical studies to predict the disposition of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand in humans: characterization of in vivo efficacy, pharmacokinetics, and safety.</a> September 19  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11561054/'>Motor evoked potentials from the external anal sphincter in patients with autosomal dominant pure spastic paraplegia linked to chromosome 2p.</a> September 19  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11561050/'>Very early onset Alzheimer's disease with spastic paraparesis associated with a novel presenilin 1 mutation (Phe237Ile).</a> September 19  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11568006/'>Apo2L/TRAIL and Bcl-2-related proteins regulate type I interferon-induced apoptosis in multiple myeloma.</a> September 25  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11857034/'>Resistance of prostate cancer cells to soluble TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) can be overcome by doxorubicin or adenoviral delivery of full-length TRAIL.</a> February 22  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/11912124/'>Requirement of BAX for TRAIL/Apo2L-induced apoptosis of colorectal cancers: synergism with sulindac-mediated inhibition of Bcl-x(L).</a> March 26  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12010810/'>Biologic sequelae of nuclear factor-kappaB blockade in multiple myeloma: therapeutic applications.</a> May 16  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12029096/'>Identification of X-linked inhibitor of apoptosis-associated factor-1 as an interferon-stimulated gene that augments TRAIL Apo2L-induced apoptosis.</a> May 25  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12097388/'>IFN-beta pretreatment sensitizes human melanoma cells to TRAIL/Apo2 ligand-induced apoptosis.</a> July 5  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12118245/'>Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo.</a> July 16  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12140294/'>Regulation of TRAIL expression by the phosphatidylinositol 3-kinase/Akt/GSK-3 pathway in human colon cancer cells.</a> July 26  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12154014/'>Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II.</a> August 3  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12496481/'>Doxorubicin pretreatment sensitizes prostate cancer cell lines to TRAIL induced apoptosis which correlates with the loss of c-FLIP expression.</a> December 24  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12496480/'>p53: a key player in the telomere dynamics.</a> December 24  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12587790/'>Adenoviral (full-length) Apo2L/TRAIL gene transfer is an ineffective treatment strategy for malignant glioma.</a> February 18  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12610517/'>A mechanism of resistance to TRAIL/Apo2L-induced apoptosis of newly established glioma cell line and sensitisation to TRAIL by genotoxic agents.</a> March 1  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12655296/'>Apo2L/TRAIL and its death and decoy receptors.</a> March 26  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12707267/'>c-Jun N-terminal kinase contributes to apoptotic synergy induced by tumor necrosis factor-related apoptosis-inducing ligand plus DNA damage in chemoresistant, p53 inactive mesothelioma cells.</a> April 23  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12766484/'>Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis.</a> May 27  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12787570/'>Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy.</a> June 6  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12838325/'>Progressive resistance of BTK-143 osteosarcoma cells to Apo2L/TRAIL-induced apoptosis is mediated by acquisition of DcR2/TRAIL-R4 expression: resensitisation with chemotherapy.</a> July 3  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12907654/'>Apoptosis induction in prostate cancer cells and xenografts by combined treatment with Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand and CPT-11.</a> August 9  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12916874/'>Role of Apo2L/TRAIL and Bcl-2-family proteins in apoptosis of multiple myeloma.</a> August 15  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14601052/'>Selective and nonselective toxicity of TRAIL/Apo2L combined with chemotherapy in human bone tumour cells vs. normal human cells.</a> November 6  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14634624/'>TRAIL and apoptosis induction by TNF-family death receptors.</a> November 25  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14647152/'>Induction of apoptosis in experimental human B cell lymphomas by conditional TRAIL-expressing T cells.</a> December 4  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14720446/'>[Synergistic effect of Apo2L and chemotherapeutic agents on leukemia cells].</a> January 15  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/14726646/'>Arsenic trioxide and paclitaxel induce apoptosis by different mechanisms.</a> January 17  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/14999225/'>AAV-encoded expression of TRAIL in experimental human colorectal cancer leads to tumor regression.</a> March 5  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15004796/'>Quantification of tumor tissue populations by multispectral analysis.</a> March 9  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15110178/'>FLIP protein and TRAIL-induced apoptosis.</a> April 28  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15110174/'>TRAIL and NFkappaB signaling--a complex relationship.</a> April 28  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15118763/'>Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis.</a> May 1  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15173176/'>Caspase-2 can function upstream of bid cleavage in the TRAIL apoptosis pathway.</a> June 3  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15251125/'>Targeting death receptors in cancer with Apo2L/TRAIL.</a> July 15  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15269523/'>High-level production of soluble tumor necrosis factor-related apoptosis-inducing ligand (Apo2L/TRAIL) in high-density cultivation of recombinant Escherichia coli using a combined feeding strategy.</a> July 23  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15282212/'>Tissue distribution, stability, and pharmacokinetics of Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand in human colon carcinoma COLO205 tumor-bearing nude mice.</a> July 30  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15389537/'>Emerging non-apoptotic functions of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/Apo2L.</a> September 25  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15520016/'>Receptor-selective mutants of apoptosis-inducing ligand 2/tumor necrosis factor-related apoptosis-inducing ligand reveal a greater contribution of death receptor (DR) 5 than DR4 to apoptosis signaling.</a> November 3  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15547696/'>Sensitization of multidrug resistant human ostesarcoma cells to Apo2 Ligand/TRAIL-induced apoptosis by inhibition of the Akt/PKB kinase.</a> November 18  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15564138/'>Adenovirus-mediated FLT1-targeted proapoptotic gene therapy of human prostate cancer.</a> November 27  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15604285/'>HPC1/RNASEL mediates apoptosis of prostate cancer cells treated with 2',5'-oligoadenylates, topoisomerase I inhibitors, and tumor necrosis factor-related apoptosis-inducing ligand.</a> December 18  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15604280/'>Elimination of hepatic metastases of colon cancer cells via p53-independent cross-talk between irinotecan and Apo2 ligand/TRAIL.</a> December 18  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15619633/'>Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells.</a> December 28  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15650163/'>Resistance to Apo2 ligand (Apo2L)/tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis and constitutive expression of Apo2L/TRAIL in human T-cell leukemia virus type 1-infected T-cell lines.</a> January 15  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/15711932/'>Recruitment of TRADD, FADD, and caspase 8 to double-stranded RNA-triggered death inducing signaling complexes (dsRNA-DISCs).</a> February 16  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/15784899/'>Dengue virus-induced apoptosis in hepatic cells is partly mediated by Apo2 ligand/tumour necrosis factor-related apoptosis-inducing ligand.</a> March 24  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/15861184/'>Chronic lymphocytic leukemic cells exhibit apoptotic signaling via TRAIL-R1.</a> April 30  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/15860671/'>Ectopic and IFN-induced expression of Fas overcomes resistance to Fas-mediated apoptosis in multiple myeloma cells.</a> April 30  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16037389/'>Neutrophil stimulation with Mycobacterium bovis bacillus Calmette-Guerin (BCG) results in the release of functional soluble TRAIL/Apo-2L.</a> July 23  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16127151/'>Cleavage of p53-vimentin complex enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis of rheumatoid arthritis synovial fibroblasts.</a> August 30  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16216337/'>Characterization and expression analysis of TNF-related apoptosis inducing ligand (TRAIL) in grass carp Ctenopharyngodon idella.</a> October 12  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16216319/'>Development and evaluation of a highly sensitive human papillomavirus genotyping DNA chip.</a> October 12  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16216317/'>The AP-2gamma transcription factor is upregulated in advanced-stage ovarian carcinoma.</a> October 12  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16227629/'>Molecular determinants of kinase pathway activation by Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand.</a> October 18  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16314473/'>Potential pathogenetic implications of cyclooxygenase-2 overexpression in B chronic lymphoid leukemia cells.</a> November 30  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16368536/'>APO2 ligand/tumor necrosis factor-related apoptosis-inducing ligand in prostate cancer therapy.</a> December 22  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16550602/'>The histone deacetylase inhibitor, suberoylanilide hydroxamic acid, overcomes resistance of human breast cancer cells to Apo2L/TRAIL.</a> March 22  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16554833/'>Genetically encoded fluorescent indicator for intracellular hydrogen peroxide.</a> March 24  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16681723/'>Synergistic antitumor effect of tumor necrosis factor-related apoptosis-inducing ligand combined with cisplatin in ovarian carcinoma cell lines in vitro and in vivo.</a> May 10  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16891471/'>Multiple mechanisms underlie resistance of leukemia cells to Apo2 Ligand/TRAIL.</a> August 8  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16925970/'>The essential role of the mitochondria-dependent death-signaling cascade in chemotherapy-induced potentiation of Apo2L/TRAIL cytotoxicity in cultured thoracic cancer cells: amplified caspase 8 is indispensable for combination-mediated massive cell death.</a> August 24  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16957768/'>Adenoviral expression of XIAP antisense RNA induces apoptosis in glioma cells and suppresses the growth of xenografts in nude mice.</a> September 8  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17178886/'>Dimethylfumarate impairs melanoma growth and metastasis.</a> December 21  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17178885/'>Cationic albumin-conjugated pegylated nanoparticles allow gene delivery into brain tumors via intravenous administration.</a> December 21  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17289836/'>Curcumin [1,7-bis(4-hydroxy-3-methoxyphenyl)-1-6-heptadine-3,5-dione; C21H20O6] sensitizes human prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L-induced apoptosis by suppressing nuclear factor-kappaB via inhibition of the prosurvival Akt signaling pathway.</a> February 10  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17440816/'>Expression of anti-apoptotic factors modulates Apo2L/TRAIL resistance in colon carcinoma cells.</a> April 19  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17479107/'>Cytosine deaminase/5-fluorocytosine gene therapy and Apo2L/TRAIL cooperate to kill TRAIL-resistant tumor cells.</a> May 5  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17611406/'>Bypass NFkappaB-mediated survival pathways by TRAIL and Smac.</a> July 6  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17653094/'>Reversal of methylation silencing of Apo2L/TRAIL receptor 1 (DR4) expression overcomes resistance of SK-MEL-3 and SK-MEL-28 melanoma cells to interferons (IFNs) or Apo2L/TRAIL.</a> July 27  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17892398/'>Requirement of catalytically active Tyk2 and accessory signals for the induction of TRAIL mRNA by IFN-beta.</a> September 26  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18178561/'>TRAIL stimulates proliferation of vascular smooth muscle cells via activation of NF-kappaB and induction of insulin-like growth factor-1 receptor.</a> January 8  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18202704/'>A novel p53 rescue compound induces p53-dependent growth arrest and sensitises glioma cells to Apo2L/TRAIL-induced apoptosis.</a> January 19  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18336195/'>Tumor necrosis factor: renaissance as a cancer therapeutic?</a> March 14  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18495520/'>Targeting the extrinsic apoptosis pathway in cancer.</a> May 23  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18495513/'>Emergence of an independent lineage of dengue virus type 1 (DENV-1) and its co-circulation with predominant DENV-3 during the 2006 dengue fever outbreak in Delhi.</a> May 23  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18507029/'>Valproic acid sensitizes K562 erythroleukemia cells to TRAIL/Apo2L-induced apoptosis.</a> May 30  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18523647/'>To kill a tumor cell: the potential of proapoptotic receptor agonists.</a> June 5  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18640940/'>Ligand-based targeting of apoptosis in cancer: the potential of recombinant human apoptosis ligand 2/Tumor necrosis factor-related apoptosis-inducing ligand (rhApo2L/TRAIL).</a> July 22  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18645027/'>Cloning and apoptosis-inducing activities of canine and feline TRAIL.</a> July 23  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18714167/'>Synergism of CPT-11 and Apo2L/TRAIL against two differentially sensitive human colon tumor xenografts.</a> August 21  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18989337/'>Directing cancer cells to self-destruct with pro-apoptotic receptor agonists.</a> November 8  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19214542/'>Stem-cell-like glioma cells are resistant to TRAIL/Apo2L and exhibit down-regulation of caspase-8 by promoter methylation.</a> May 20  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19214536/'>IGR2096a_1 T and IGR2198a_1 C alleles on IBD5 locus of chromosome 5q31 region confer risk for Crohn's disease in Hungarian patients.</a> May 19  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19265041/'>TRAIL/Apo2L mediates the release of procoagulant endothelial microparticles induced by thrombin in vitro: a potential mechanism linking inflammation and coagulation.</a> May 8  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19276263/'>Apo2L/TRAIL inhibits tumor growth and bone destruction in a murine model of multiple myeloma.</a> April 17  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19455405/'>Experimental testing of a mathematical model relevant to the extrinsic pathway of apoptosis.</a> February 25  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20556479/'>Therapeutic effects of the Sp1 inhibitor mithramycin A in glioblastoma.</a> May 6  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20804743/'>Pentoxifylline augments TRAIL/Apo2L mediated apoptosis in cutaneous T cell lymphoma (HuT-78 and MyLa) by modulating the expression of antiapoptotic proteins and death receptors.</a> November 6  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21603612/'>NFATc1 regulation of TRAIL expression in human intestinal cells.</a> October 22  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21603610/'>Identification of methylated genes associated with aggressive clinicopathological features in mantle cell lymphoma.</a> October 22  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21824725/'>Radiotherapy and TRAIL for cancer therapy.</a> June 26  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22116828/'>The calcineurin B subunit (CnB) is a new ligand of integrin αM that mediates CnB-induced Apo2L/TRAIL expression in macrophages.</a> February 18  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22230480/'>Targeting the Apo2L/TRAIL system for the therapy of autoimmune diseases and cancer.</a> June 1  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22666346/'>Dihydroartemisinin enhances Apo2L/TRAIL-mediated apoptosis in pancreatic cancer cells via ROS-mediated up-regulation of death receptor 5.</a> October 30  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23431365/'>Apigenin sensitizes prostate cancer cells to Apo2L/TRAIL by targeting adenine nucleotide translocase-2.</a> August 16  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23431363/'>Association between Methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to cervical cancer: a meta-analysis.</a> August 16  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23974204/'>Aurora and IKK kinases cooperatively interact to protect multiple myeloma cells from Apo2L/TRAIL.</a> December 16  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24086526/'>Sorafenib sensitizes solid tumors to Apo2L/TRAIL and Apo2L/TRAIL receptor agonist antibodies by the Jak2-Stat3-Mcl1 axis.</a> July 8  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24401154/'>Sensitization of hepatocellular carcinoma cells to Apo2L/TRAIL by a novel Akt/NF-κB signalling inhibitor.</a> February 3  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24401153/'>Genetic diversity of Plasmodium vivax population in Anhui province of China.</a> September 16  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24466325/'>TRAIL/DR5 signaling promotes macrophage foam cell formation by modulating scavenger receptor expression.</a> September 30  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24736722/'>Characterization of the role of tumor necrosis factor apoptosis inducing ligand (TRAIL) in spermatogenesis through the evaluation of trail gene-deficient mice.</a> January 7  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26321244/'>Fut3 role in breast invasive ductal carcinoma: Investigating its gene promoter and protein expression.</a> April 23  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26321232/'>Genetic association of Fc receptor-like glycoprotein with susceptibility to Graves' disease in a Chinese Han population.</a> August 17  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26516157/'>Dual Agonist Surrobody Simultaneously Activates Death Receptors DR4 and DR5 to Induce Cancer Cell Death.</a> October 19  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26514480/'>TRAIL in Combination with Subtoxic 5-FU Effectively Inhibit Cell Proliferation and Induce Apoptosis in Cholangiocarcinoma Cells.</a> August 17  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26514476/'>Tobacco Use Increases Oxidative DNA Damage in Sperm - Possible Etiology of Childhood Cancer.</a> August 17  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26514474/'>Influence of the CYP1A1 T3801C Polymorphism on Tobacco and Alcohol-Associated Head and Neck Cancer Susceptibility in Northeast India.</a> August 17  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26514473/'>Hesa-A Down-Regulates erb/b2 Oncogene Expression and Improves Outcome of Oral Carcinoma in a Rat Model.</a> August 17  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26514459/'>Meningeal Hemangiopericytomas and Meningomas: a Comparative Immunohistochemical and Genetic Study.</a> August 10  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26514456/'>Expression of Fatty Acid Synthase Negatively Correlates with PTEN and Predicts Peritoneal Dissemination of Human Gastric Cancer.</a> August 10  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26514455/'>Molecular Screening for P53 Mutations among Tobacco Smokers in a Survey of Awareness of Links between Tobacco, Alcohol Use and Cancer in Saudi Arabia.</a> August 10  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26542757/'>Epigenetic inactivation of TRAIL decoy receptors at 8p12-21.3 commonly deleted region confers sensitivity to Apo2L/trail-Cisplatin combination therapy in cervical cancer.</a> October 16  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26542756/'>Predictive or not predictive: understanding the mixed messages from the patient's DNA sequence.</a> September 23  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26542751/'>Functional polymorphisms in the gene encoding macrophage migration inhibitory factor (MIF) are associated with active pulmonary tuberculosis.</a> June 23  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26943263/'>TRAIL causes deletions at the HPRT and TK1 loci of clonogenically competent cells.</a> August 19  2016<br></body></html>
